Nevirapine combined with Tenofovir

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Po2 Increased Hospitalization 3/27/2004 60 Male 1/5/2006
Primary
Secondary
Gallbladder Cancer Hospitalization 4/29/2004 Male 117 lb 1/5/2006
Primary
Concomitant
Viral Mutation Identified Other Serious Female 2/23/2006
Primary
Secondary
Ventricular Dysfunction Other Serious 1/1/2005 38 Female 110 lb 3/6/2006 Other Health Professional France
Primary
Secondary
Concomitant
Viral Mutation Identified Other Serious 3/21/2006
Primary
Secondary
Toxoplasmosis Disability 37 Male 143 lb 3/22/2006 Physician Germany
Primary
Secondary
Concomitant
Weight Decreased Other Serious 5/1/2001 Male 143 lb 3/27/2006 Physician Germany
Primary
Secondary
Concomitant
Weight Decreased Other Serious 1/1/1998 42 Male 143 lb 3/27/2006 Physician Germany
Primary
Secondary
Concomitant
Transaminases Increased Other Serious 1/30/2003 40 Male 3/27/2006 Physician Germany
Primary
Secondary
Concomitant
Weight Gain Poor Other Serious 1/1/2001 Male 181 lb 3/27/2006 Physician Germany
Primary
Secondary
Concomitant
Weight Decreased Other Serious 1/1/2002 38 Male 141 lb 3/28/2006 Physician Germany
Primary
Secondary
Concomitant
Weight Decreased Other Serious 5/1/2001 Male 3/28/2006 Physician Germany
Primary
Secondary
Concomitant
Toxoplasmosis Disability 37 Male 3/29/2006 Physician Germany
Primary
Secondary
Concomitant
Vomiting Hospitalization 33 Female 4/14/2006
Primary
Secondary
Concomitant
Hypophosphataemia Death 3/23/2006 46 Male 155 lb 4/12/2006 Consumer United States
Primary
Secondary
Concomitant
Syncope Other Serious 1/6/2004 Male 4/17/2006 Other Health Professional Germany
Primary
Secondary
Tuberculosis Other Serious 1/1/1997 54 Male 4/17/2006 Other Health Professional Germany
Primary
Secondary
Concomitant
Vertigo Other Serious 7/1/2003 Male 163 lb 4/17/2006 Physician Germany
Primary
Secondary
Concomitant
Rales Hospitalization 1/1/2003 Male 196 lb 4/17/2006 Other Health Professional Germany
Primary
Secondary
Concomitant
Weight Decreased Other Serious 4/1/1998 Male 139 lb 5/8/2006 Other Health Professional Germany
Primary
Secondary
Concomitant
Weight Increased Other Serious 1/1/1999 Male 134 lb 5/8/2006 Physician Germany
Primary
Secondary
Concomitant
Viral Mutation Identified Other Serious 5/17/2006
Primary
Secondary
Weight Decreased Other Serious 4/1/1998 Male 139 lb 5/18/2006 Other Health Professional Germany
Primary
Secondary
Concomitant
Intracranial Aneurysm Life Threatening 9/25/2005 Male 5/26/2006 United Kingdom
Primary
Concomitant
Death Death 11/1/2004 Male 6/16/2006 United States
Primary
Concomitant
Death Death 11/1/2004 Male 6/16/2006 United States
Primary
Concomitant
Viral Mutation Identified Death 11/1/2001 39 Male 6/20/2006
Primary
Secondary
Weight Decreased Other Serious Female 7/6/2006
Primary
Secondary
Premature Baby Other Serious 7/7/2006
Primary
Secondary
Premature Baby Other Serious Female 7/14/2006 Germany
Primary
Secondary
Weight Decreased Other Serious 33 Female 7/14/2006 Germany
Primary
Secondary
Concomitant
Thrombocytopenia Other Serious 9/27/2004 Male 7/27/2006 Physician Japan
Primary
Secondary
Concomitant
Thrombocytopenia Other Serious 9/27/2004 Male 8/4/2006 Physician Japan
Primary
Secondary
Concomitant
Renal Tubular Necrosis Hospitalization 12/29/2004 38 Male 95 lb 8/8/2006 Consumer Australia
Primary
Secondary
Concomitant
Viral Mutation Identified Other Serious Male 8/15/2006
Primary
Secondary
Intracranial Aneurysm Life Threatening 9/25/2005 Male 8/15/2006 United Kingdom
Primary
Concomitant
Hepatitis Cholestatic Hospitalization 4/23/2006 39 Male 8/21/2006 Other Health Professional Spain
Primary
Secondary
Premature Baby Other Serious Female 8/21/2006 Germany
Primary
Secondary
Weight Decreased Other Serious 33 Female 8/21/2006 Germany
Primary
Secondary
Concomitant
Vomiting Hospitalization 9/19/2005 39 Male 8/8/2006 Pharmacist United States
Primary
Concomitant
Productive Cough Other Serious 9/10/2001 Male 9/13/2006 Physician Japan
Primary
Secondary
Concomitant
Rib Fracture Other Serious 1/1/1996 Male 9/13/2006
Primary
Secondary
Concomitant
Death Death 6/30/2005 Male 10/12/2006 United States
Primary
Concomitant
Intracranial Aneurysm Life Threatening 9/25/2005 Male 10/13/2006 United Kingdom
Primary
Concomitant
Productive Cough Other Serious 9/10/2001 Male 10/27/2006 Physician Japan
Primary
Secondary
Concomitant
Weight Decreased Other Serious Female 10/30/2006
Primary
Secondary
Premature Baby Other Serious 10/30/2006
Primary
Secondary
Gallbladder Polyp Hospitalization 4/29/2004 Male 117 lb 11/20/2006
Primary
Concomitant
Weight Decreased Other Serious Female 12/6/2006
Primary
Secondary
Overdose Other Serious 5/17/1999 Male 12/7/2006 Physician Japan
Primary
Secondary
Concomitant
Stevens-johnson Syndrome Death 11/13/2006 29 Male 106 lb 12/7/2006 Other Health Professional United States
Primary
Secondary
Stevens-johnson Syndrome Death 11/13/2006 50 Male 106 lb 12/29/2006 Other Health Professional United States
Primary
Secondary
Hepatitis B Other Serious 47 Male 1/17/2007
Primary
Secondary
Neutropenia Other Serious 1/1/2004 Male 1/25/2007 Consumer United Kingdom
Primary
Secondary
Concomitant
Weight Decreased Other Serious 12/28/1999 Male 1/25/2007 Physician Japan
Primary
Secondary
Concomitant
Nodular Regenerative Hyperplasia Hospitalization 39 Male 2/7/2007 Physician France
Primary
Secondary
Glucose Tolerance Impaired Other Serious 9/22/2004 Male 4/5/2007 Physician Japan
Primary
Secondary
Concomitant
Tachycardia Hospitalization 10/22/2006 Female 154 lb 10/23/2006 Pharmacist United States
Primary
Concomitant
Gallbladder Polyp Hospitalization 4/29/2004 Male 117 lb 4/19/2007
Primary
Concomitant
Drug Interaction Other Serious Male 4/23/2007
Primary
Secondary
Vertical Infection Transmission Other Serious 5/3/2007
Primary
Secondary
Hypertriglyceridaemia Other Serious 8/1/2001 39 Male 5/1/2007 Other Health Professional Canada
Primary
Secondary
Concomitant
Glucose Tolerance Impaired Other Serious 9/22/2004 Male 5/23/2007 Physician Japan
Primary
Secondary
Concomitant
Tuberculosis Hospitalization 53 Male 5/17/2007 France
Primary
Secondary
Concomitant
White Blood Cell Count Decreased Other Serious 9/10/2001 Male 6/7/2007 Physician Japan
Primary
Secondary
Concomitant
White Blood Cell Count Decreased Other Serious 9/10/2001 Male 6/14/2007 Physician Japan
Primary
Secondary
Concomitant
Weight Decreased Other Serious 12/28/1999 Male 6/15/2007 Physician Japan
Primary
Secondary
Concomitant
Portal Hypertension Other Serious 27 Male 6/19/2007
Primary
Secondary
Concomitant
Torsade De Pointes Hospitalization 1/1/2006 53 Female 6/19/2007
Primary
Secondary
Concomitant
Migraine Other Serious 5/7/2007 43 Male 170 lb 6/14/2007 Other Health Professional United Kingdom
Primary
Concomitant
Visceral Leishmaniasis Other Serious 3/1/2000 46 Male 10/19/2007 Other Health Professional Italy
Primary
Secondary
Visceral Leishmaniasis Other Serious 3/1/2000 46 Male 10/22/2007 Other Health Professional Italy
Primary
Secondary
Vomiting Other Serious 1/7/2008 Physician United Kingdom
Primary
Secondary
Concomitant
Vanishing Bile Duct Syndrome Hospitalization 25 Male 1/9/2008 United Kingdom
Primary
Secondary
Concomitant
Meconium In Amniotic Fluid Hospitalization 4/12/2007 Female 1/14/2008 Physician
Primary
Concomitant
Vomiting Life Threatening 25 Male 1/22/2008 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
Vanishing Bile Duct Syndrome Other Serious 25 Male 1/23/2008 United Kingdom
Primary
Secondary
Concomitant
Gun Shot Wound Death 6/30/2005 Male 2/27/2008 United States
Primary
Concomitant
White Blood Cell Count Decreased Other Serious 9/10/2001 Male 3/13/2008 Physician Japan
Primary
Secondary
Concomitant
Vanishing Bile Duct Syndrome Other Serious 25 Male 3/7/2008 United Kingdom
Primary
Concomitant
Weight Decreased Other Serious Female 3/19/2008
Primary
Secondary
Portal Hypertension Other Serious 50 Male 3/31/2008 Physician Netherlands
Primary
Concomitant
Sex Hormone Binding Globulin Decreased Other Serious 49 Male 3/31/2008
Primary
Secondary
Concomitant
Hepatic Failure Other Serious 3/1/2007 50 Male 4/1/2008 Physician Netherlands
Primary
Concomitant
Pyelocaliectasis Congenital Anomaly Female 4/14/2008
Primary
Secondary
Lipoatrophy Other Serious 1/24/2008 39 Female 5/16/2008 Physician Zimbabwe
Primary
Secondary
Concomitant
Lipoatrophy Other Serious 1/24/2008 39 Female 5/20/2008 Physician Zimbabwe
Primary
Secondary
Concomitant
Neuropathy Peripheral Other Serious 1/1/2000 Male 6/3/2008
Primary
Secondary
Concomitant
Tremor Other Serious 52 Male 6/25/2008 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
Vomiting Hospitalization 5/19/2008 28 Female 6/30/2008 Physician Zimbabwe
Primary
Secondary
Concomitant
Viral Load Increased Other Serious 39 Male 7/10/2008 Other Health Professional United States
Primary
Concomitant
Interacting
Rash Other Serious 39 Male 9/11/2008 Other Health Professional United States
Primary
Secondary
Pneumocystis Jiroveci Pneumonia Other Serious 22 Male 9/12/2008 Physician United States
Primary
Secondary
Concomitant
Rash Other Serious 9/16/2008 Other Health Professional United States
Primary
Secondary
Concomitant
Therapeutic Response Decreased Other Serious 47 Male 9/17/2008 Other Health Professional United States
Primary
Secondary
Pneumocystis Jiroveci Pneumonia Other Serious 22 Male 9/17/2008 United States
Primary
Secondary
Concomitant
Prothrombin Time Prolonged Required Intervention 38 Female 9/22/2008 France
Primary
Secondary
Concomitant
Weight Increased Other Serious Male 195 lb 10/17/2008 United States
Primary
Secondary
Concomitant
Peripheral Sensory Neuropathy Other Serious Male 10/29/2008
Primary
Secondary
Pyelocaliectasis Congenital Anomaly Female 11/7/2008
Primary
Secondary
Ophthalmoplegia Other Serious 47 Male 11/14/2008 United States
Primary
Secondary
Concomitant
Varices Oesophageal Other Serious Female 12/11/2008
Primary
Secondary
Portal Hypertension Other Serious 27 Male 1/9/2009
Primary
Secondary
Concomitant
Neoplasm Malignant Other Serious Male 2/17/2009
Primary
Secondary
Weight Decreased Other Serious 12/18/2007 63 Male 2/20/2009 Physician Zimbabwe
Primary
Secondary
Concomitant
Pregnancy Other Serious 38 Female 3/24/2009 Other Health Professional United Kingdom
Primary
Secondary
Injection Site Reaction Other Serious 38 Female 3/26/2009 Physician Nigeria
Primary
Secondary
Pregnancy Other Serious 38 Female 3/26/2009 Other Health Professional United Kingdom
Primary
Secondary
Weight Increased Other Serious 29 Female 4/6/2009 United Kingdom
Primary
Secondary
Concomitant
Platelet Count Decreased Other Serious 3/20/2009 Male 190 lb 4/10/2009 Physician Australia
Primary
Secondary
Concomitant
Weight Increased Other Serious 29 Female 4/14/2009 United Kingdom
Primary
Concomitant
Interacting
Lipodystrophy Acquired Other Serious 40 Male 4/15/2009 Other Health Professional United States
Primary
Secondary
Ill-defined Disorder Other Serious 3/4/2009 Female 5/1/2009 Physician United Kingdom
Primary
Secondary
Ventricular Tachycardia Life Threatening 57 Male 5/7/2009
Primary
Secondary
Liver Disorder Other Serious 45 Male 5/8/2009
Primary
Secondary
Liver Disorder Other Serious 42 Male 5/8/2009
Primary
Secondary
Drug Exposure During Pregnancy Other Serious 3/4/2009 Female 5/20/2009 Other Health Professional United Kingdom
Primary
Secondary
Gastroenteritis Viral Hospitalization 4/18/2005 43 5/25/2009 Other Health Professional Canada
Primary
Concomitant
Nodular Regenerative Hyperplasia Other Serious 5/1/2007 38 Female 6/10/2009 Other Health Professional France
Primary
Secondary
Nodular Regenerative Hyperplasia Other Serious 6/19/2009 Consumer France
Primary
Secondary
Weight Decreased Other Serious 12/28/1999 Male 6/25/2009 Physician Japan
Primary
Secondary
Concomitant
Jaundice Hospitalization 4/24/2007 55 Male 7/2/2009 Consumer United Kingdom
Primary
Concomitant
Jaundice Hospitalization 4/24/2007 55 Male 7/6/2009 Consumer United Kingdom
Primary
Concomitant
Virologic Failure Other Serious 29 Female 7/10/2009
Primary
Secondary
Concomitant
Platelet Count Decreased Other Serious 3/20/2009 Male 190 lb 7/15/2009 Physician Australia
Primary
Secondary
Concomitant
Progressive External Ophthalmoplegia Other Serious 54 Male 7/31/2009
Primary
Secondary
Progressive External Ophthalmoplegia Other Serious 52 Male 7/31/2009
Primary
Secondary
Platelet Count Decreased Other Serious 3/20/2009 Male 190 lb 8/13/2009 Physician Australia
Primary
Secondary
Concomitant
Ventricular Tachycardia Life Threatening 57 Male 8/21/2009
Primary
Secondary
Toxic Epidermal Necrolysis Hospitalization Female 8/27/2009
Primary
Secondary
Varices Oesophageal Hospitalization 57 Male 8/27/2009
Primary
Secondary
Vascular Injury Hospitalization 48 Female 8/27/2009
Primary
Secondary
Varices Oesophageal Hospitalization 40 Male 8/27/2009
Primary
Secondary
Varices Oesophageal Hospitalization 43 Female 8/27/2009
Primary
Secondary
Pulmonary Hypertension Other Serious 43 Female 9/4/2009 Other Health Professional Spain
Primary
Secondary
Progressive External Ophthalmoplegia Other Serious 52 Male 9/8/2009 Consumer United States
Primary
Secondary
Portal Hypertension Other Serious 57 Male 9/9/2009 Other Health Professional Spain
Primary
Secondary
Portal Hypertension Other Serious 40 Male 9/9/2009 Other Health Professional Spain
Primary
Secondary
Portal Hypertension Other Serious 48 Female 9/9/2009 Other Health Professional Spain
Primary
Secondary
Portal Hypertension Other Serious 43 Female 9/9/2009 Other Health Professional Spain
Primary
Secondary
Pyrexia Hospitalization 54 9/10/2009
Primary
Secondary
Portal Hypertension Other Serious 57 Male 9/14/2009 Other Health Professional Spain
Primary
Secondary
Portal Hypertension Other Serious 40 Male 9/14/2009 Other Health Professional Spain
Primary
Secondary
Portal Hypertension Other Serious 48 Female 9/14/2009 Other Health Professional Spain
Primary
Secondary
Portal Hypertension Other Serious 43 Female 9/14/2009 Other Health Professional Spain
Primary
Secondary
Portal Hypertensive Gastropathy Other Serious 57 Male 9/11/2009 Spain
Primary
Secondary
Pulmonary Hypertension Other Serious 43 Female 9/17/2009 Other Health Professional Spain
Primary
Secondary
Progressive External Ophthalmoplegia Other Serious 52 Male 9/17/2009 Other Health Professional Canada
Primary
Secondary
Splenomegaly Other Serious 40 Male 9/11/2009
Primary
Secondary
Varices Oesophageal Other Serious 48 Female 9/11/2009
Primary
Secondary

Drug Data